RadNet's (RDNT) DeepHealth unit said Friday it received expanded US Food and Drug Administration 510(k) clearance for its SmartMammo mammography software.
The unit added that its SmartMammo Dx artificial intelligence algorithm is now compatible with GE HealthCare Technologies' (GEHC) Senographe Pristina mammography systems.
The unit said radiologists use the SmartMammo mammography software to analyze digital breast tomosynthesis mammograms with precision.
Shares of RadNet were up 1.8% in recent Friday premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.